Evaluation of Genetically Inactivated Alpha Toxin for Protection in Multiple Mouse Models of Staphylococcus aureus Infection

• Rebecca A. Brady,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Christopher P. Mocca,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Ranjani Prabhakara,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Roger D. Plaut,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Mark E. Shirtliff,

  Affiliations Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, United States of America, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Tod J. Merkel,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Drusilla L. Burns

  * E-mail: drusilla.burns@fda.hhs.gov

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯